Here are some of the latest headlines from Wisconsin’s innovation community:
—FluGen, a Madison-based company trying to develop a universal influenza vaccine, announced topline, preliminary data from a Phase 2 study that demonstrated its M2SR vaccine proved effective in countering a... Read more »
Too many people treat pet adoption like a one-night stand.
“You look at a dog, and see his eyes, and think he’s cute,” says Tama Lundquist, co-president of Houston PetSet, an organization that works with about 70 animal shelters in the... Read more »
Some people relish the opportunity to give feedback to individuals and organizations that have served them—think Yelp and Google users who rate every restaurant where they’ve eaten. Others may be less eager to evaluate a recent Uber trip, for example, but... Read more »
San Antonio — VelocityTX is getting a $750,000 grant and another tax incentive from the City of San Antonio for its redevelopment of a large industrial space that VelocityTX plans to turn into a three-building “innovation center” for tech, life sciences,... Read more »
General Electric is backing out of its glitzy Boston ambitions, selling the land it planned to hold a new 12-story headquarters for 800 employees and instead retreating into the two brick buildings on the same site that can hold 250 workers,... Read more »
After a whirlwind courtship and brief engagement, Amazon has broken off its plans to establish another headquarters in New York’s Long Island City neighborhood.
Amazon (NASDAQ: AMZN) rationalized its Valentine’s Day breakup with the Big Apple by saying that the... Read more »
Longtime biopharmaceutical executive Tachi Yamada helped keep the work of gene therapy pioneer James Wilson alive 20 years ago when Wilson was mired in controversy and the emerging field was in its darkest days.
Now that gene therapy has come of... Read more »
Cibus on Thursday said it is holding off on the initial public offering that was expected to happen this week.
“We elected to postpone our offering given current market and technical conditions,” said co-founder and CEO Peter Beetham in a press... Read more »
Cancer immunotherapy developer TCR² Therapeutics has raised $75 million in an IPO, which it will use for clinical trials to test a type of immunotherapy intended to treat a wider range of cancers than current cell therapies.
Late Wednesday, TCR² priced... Read more »
By now, many consumers know that uploading a photo, video, or other file to “the cloud” on a service like Google or Facebook often means storing it in a data center. But the computer servers inside data centers don’t just store... Read more »
[Updated 9:20 p.m., see below.] DBV Technologies is jumping back into the race to bring an FDA-approved peanut allergy treatment to the market, but it might not be enough to beat its main rival.
The France-based company says it... Read more »
Mission Edge, a nonprofit organization backed by the San Diego Foundation and three corporations, has chosen 10 companies and organizations to participate in a 12-week program intended to improve each entity’s financial performance, and thereby long-term sustainability.
Called the Social Enterprise... Read more »
[Updated 2:07 p.m. See below.] Johnson & Johnson is acquiring medical robotics developer Auris Health for $3.4 billion in cash, a deal that builds on the company’s stated plans to become a player in “digital surgery.”
Privately held Auris... Read more »